Abela Agnarsson
Has Masters of Medical Sciences in Molecular Cell Biology from Södertörn University College, Sweden. Abela worked with the Swedish CDC before starting her post graduate studies at IHCAR. Her thesis is within the ARVMAC project focusing on where the access and uptake of HIV/AIDS care in relation to antiretroviral treatment (ART) scale-up in three demographic surveillance system; in Tanzania (Rufiji), Uganda (Iganga-Mayuge) and Burkina Faso (Nouna) DSS.
